Dilated Cardiomyopathy May Be Associated With a Novel Mitochondrial tRNASer(AGY) Mutation

Yu Ding1, Xuejiao Yu2, Jian Xu1

  • 1Department of Clinical Laboratory, Hangzhou First People's Hospital, Hangzhou, Zhejiang, China.

Human Mutation
|June 16, 2025
PubMed

Insights

Mitochondrial tRNA mutations, including a novel m.12265A>G, are linked to dilated cardiomyopathy (DCM). These mutations impair mitochondrial function, affecting ATP production and increasing ROS, contributing to heart failure risk.

Area of Science:

  • Genetics
  • Mitochondrial Biology
  • Cardiology

Background:

  • Dilated cardiomyopathy (DCM) is a significant cause of heart failure.
  • Mitochondrial dysfunction, particularly due to mitochondrial transfer RNA (mt-tRNA) mutations, is increasingly implicated in DCM pathogenesis.
  • The precise mechanisms linking mt-tRNA mutations to DCM remain incompletely understood.

Purpose of the Study:

  • To identify and characterize novel mt-tRNA mutations associated with maternally inherited DCM.
  • To investigate the functional consequences of identified mt-tRNA mutations on mitochondrial function.
  • To elucidate the role of these mutations in the development of DCM.

Main Methods:

  • Genetic analysis of a Chinese family with maternally inherited DCM to identify mutations.
  • Characterization of a novel m.12265A>G mutation in mt-tRNASer(AGY) and a known m.5821G>A mutation in mt-tRNACys.
  • Transmitochondrial cybrid studies to assess mitochondrial function in cells harboring the identified mutations.

Main Results:

  • A novel m.12265A>G mutation in mt-tRNASer(AGY) and a known m.5821G>A mutation in mt-tRNACys were identified in a DCM pedigree.
  • Mutations affected conserved regions of mt-tRNAs, including the acceptor arm and base pairing.
  • Cybrid cells with these mutations exhibited impaired mitochondrial function: reduced ATP, membrane potential, mtDNA content, and respiratory complex activities.
  • Mutant cells showed increased reactive oxygen species (ROS), calcium, and lactate levels.

Conclusions:

  • The identified m.12265A>G and m.5821G>A mutations impair mitochondrial metabolism and function.
  • These mitochondrial dysfunctions are implicated in the pathogenesis of dilated cardiomyopathy.
  • The study expands the understanding of genotypic variations in mt-tRNA mutations linked to human diseases.

Related Concept Videos

Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
8.1K
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
15.3K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
67
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
145.4K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
72